Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[German multicenter thalassemia study. Concept and initial results].

E Kohne1, K Stahnke, A E Kulozik

  • 1Universitäts-Kinderklinik Ulm.

Klinische Padiatrie
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The beta thalassaemia trait in Jamaica.

Journal of community genetics·2023
Same author

Hb Santa Juana (<i>β</i> 108(G10) Asn > Ser): a low oxygen affinity hemoglobin variant in a family of Bosnian background.

Hematology (Amsterdam, Netherlands)·2023
Same author

The haematology of Jamaicans: red cell indices in HbAA, HbAS, HbAC, and HbA-HPFH genotypes.

Journal of community genetics·2022
Same author

Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.

Annals of hematology·2021
Same author

Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis.

Leukemia·2017
Same author

Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.

Blood cancer journal·2017

This study on Thalassaemia major in Germany found that many young patients need improved transfusion therapy and iron chelation. Optimizing treatment protocols is crucial for better long-term outcomes and quality of life.

Area of Science:

  • Pediatric Hematology
  • Genetic Blood Disorders

Background:

  • Over 300 children and adolescents in Germany have Thalassaemia major.
  • Current treatment protocols may be suboptimal, necessitating standardized therapeutic approaches.

Purpose of the Study:

  • To implement and evaluate a standardized therapy protocol for Thalassaemia major patients.
  • To assess the effectiveness and side effects of the protocol in a multi-center study.
  • To identify areas for improving patient care and long-term prognosis.

Main Methods:

  • A multi-center study initiated in April 1991 involving children and adolescents with Thalassaemia major.
  • Therapy protocol includes regular erythrocyte transfusions to maintain hemoglobin above 10.5 g/dl.
  • Daily subcutaneous Desferal administration (40 mg/kg) for iron elimination.

Related Experiment Videos

Main Results:

  • Preliminary data from 74 patients indicate that most can benefit from improved therapy.
  • 40.9% of patients exhibited suboptimal transfusion therapy with HbF levels above 15%.
  • At least 30% of patients require intensified iron elimination therapy.

Conclusions:

  • Preliminary findings highlight the urgent need to enhance Thalassaemia major treatment in Germany.
  • The study aims to enroll all affected patients to optimize long-term quality of life and prognosis.
  • Standardized protocols are essential for improving outcomes in pediatric patients with Thalassaemia major.